A recent objective study has demonstrated that the use of adjuvant platinum-based intraperitoneal chemotherapy in patients with small-volume residual advanced-stage ovarian cancer remains limited, ...

Some biological and pharmacological considerations have induced the evaluation the use of intraperitoneal chemotherapy for the management of primary ovarian cancer. The majority of women present with ...

In clinical practice, only a few risk factors remain that can be modified based on the decisions of patients and their physicians. The surgical decision making and chemotherapy administration choices, ...

MANY WHO read the article by Glehen et al 1 in this issue of the Journal will scoff at a renewed interest in intraperitoneal chemotherapy. They will likely cite two decades of work in this field that ...